Exact Mass: 347.08975180000004

Exact Mass Matches: 347.08975180000004

Found 40 metabolites which its exact mass value is equals to given mass value 347.08975180000004, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Cephalexin

(6R,7R)-7-{[(2R)-2-amino-2-phenylacetyl]amino}-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

C16H17N3O4S (347.094)


Cephalexin is only found in individuals that have used or taken this drug. It is a semisynthetic cephalosporin antibiotic with antimicrobial activity similar to that of cephaloridine or cephalothin, but somewhat less potent. It is effective against both gram-positive and gram-negative organisms. [PubChem]Cephalexin, like the penicillins, is a beta-lactam antibiotic. By binding to specific penicillin-binding proteins (PBPs) located inside the bacterial cell wall, it inhibits the third and last stage of bacterial cell wall synthesis. Cell lysis is then mediated by bacterial cell wall autolytic enzymes such as autolysins; it is possible that cephalexin interferes with an autolysin inhibitor. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01D - Other beta-lactam antibacterials > J01DB - First-generation cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic CONFIDENCE standard compound; INTERNAL_ID 1046

   

Embramine

{2-[1-(4-bromophenyl)-1-phenylethoxy]ethyl}dimethylamine

C18H22BrNO (347.0885)


D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist Embramine is an ethanolamine H1-antihistamine.

   

N-Benzylglucamine dithiocarbamate

6-{benzyl[sulphanyl(carbonothioyl)]amino}hexane-1,2,3,4,5-pentol

C14H21NO5S2 (347.0861)


   

(4R)-4-Hydroxy-4-[6-[(5R)-5-(methoxymethyl)-2-oxo-1,3-oxazolidin-3-yl]-1,3-benzothiazol-2-yl]butanenitrile

(4R)-4-Hydroxy-4-[6-[(5R)-5-(methoxymethyl)-2-oxo-1,3-oxazolidin-3-yl]-1,3-benzothiazol-2-yl]butanenitrile

C16H17N3O4S (347.094)


   
   
   

Clanobutin

Clanobutin

C18H18ClNO4 (347.0924)


C78276 - Agent Affecting Digestive System or Metabolism > C66913 - Cholagogues or Choleretic Agents

   
   

Maybridge3_002375

Maybridge3_002375

C17H17NO5S (347.0827)


   
   
   

Cefalexin

Cefalexin

C16H17N3O4S (347.094)


CONFIDENCE standard compound; EAWAG_UCHEM_ID 3014

   

Cephalexin

Cephalexin - Dark Web Drugs

C16H17N3O4S (347.094)


A semisynthetic first-generation cephalosporin antibiotic having methyl and beta-(2R)-2-amino-2-phenylacetamido groups at the 3- and 7- of the cephem skeleton, respectively. It is effective against both Gram-negative and Gram-positive organisms, and is used for treatment of infections of the skin, respiratory tract and urinary tract. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01D - Other beta-lactam antibacterials > J01DB - First-generation cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic

   

diethyl 2-(trifluoromethoxy)phenylamino-n-methylenemalonate

diethyl 2-(trifluoromethoxy)phenylamino-n-methylenemalonate

C15H16F3NO5 (347.0981)


   
   

1-ETHYNYL-4-((4-((4-NITROPHENYL)ETHYNYL)PHENYL)ETHYNYL)BENZENE

1-ETHYNYL-4-((4-((4-NITROPHENYL)ETHYNYL)PHENYL)ETHYNYL)BENZENE

C24H13NO2 (347.0946)


   

Prasugrel Hydroxy Thiolactone

Prasugrel Hydroxy Thiolactone

C18H18FNO3S (347.0991)


   

PFI-1

2-Methoxy-N-(3-Methyl-2-Oxo-1,2,3,4-Tetrahydroquinazolin-6-Yl)benzenesulfonamide

C16H17N3O4S (347.094)


   

6-[5-({[2-(methylsulphonyl)ethyl]amino}methyl)furan-2-yl]quinazolin-4-ol

6-[5-({[2-(methylsulphonyl)ethyl]amino}methyl)furan-2-yl]quinazolin-4-ol

C16H17N3O4S (347.094)


   
   

Benzyl 2-(methylsulfonyl)-7,8-dihydropyrido[4,3-d]pyrimidine-6(5H)-carboxylate

Benzyl 2-(methylsulfonyl)-7,8-dihydropyrido[4,3-d]pyrimidine-6(5H)-carboxylate

C16H17N3O4S (347.094)


   

2-(1,4-Diazepan-1-yl)-1,3-benzothiazoletrifluoroacetic acid salt

2-(1,4-Diazepan-1-yl)-1,3-benzothiazoletrifluoroacetic acid salt

C14H16F3N3O2S (347.0915)


   

Cephalexin Diketopiperazine

Cephalexin Diketopiperazine

C16H17N3O4S (347.094)


   

L-779450

2-chloro-5-(2-phenyl-5-(pyridin-4-yl)-1H-imidazol-4-yl)phenol

C20H14ClN3O (347.0825)


L-779450 is a potent and selective B-Raf kinase inhibitor with a Kd of 2.4 nM.

   

4-[[2-[(6-methyl-4-oxo-1H-pyrimidin-2-yl)thio]-1-oxoethyl]amino]benzoic acid ethyl ester

4-[[2-[(6-methyl-4-oxo-1H-pyrimidin-2-yl)thio]-1-oxoethyl]amino]benzoic acid ethyl ester

C16H17N3O4S (347.094)


   

1-phenyl-N-[4-(pyridin-2-yl)-1,3-thiazol-2-yl]-1H-imidazole-5-carboxamide

1-phenyl-N-[4-(pyridin-2-yl)-1,3-thiazol-2-yl]-1H-imidazole-5-carboxamide

C18H13N5OS (347.0841)


   

Embramine

Embramine

C18H22BrNO (347.0885)


D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist

   

N-Benzylglucamine dithiocarbamate

6-{benzyl[sulphanyl(carbonothioyl)]amino}hexane-1,2,3,4,5-pentol

C14H21NO5S2 (347.0861)


   

(4R)-4-Hydroxy-4-[6-[(5R)-5-(methoxymethyl)-2-oxo-1,3-oxazolidin-3-yl]-1,3-benzothiazol-2-yl]butanenitrile

(4R)-4-Hydroxy-4-[6-[(5R)-5-(methoxymethyl)-2-oxo-1,3-oxazolidin-3-yl]-1,3-benzothiazol-2-yl]butanenitrile

C16H17N3O4S (347.094)


   
   

4-chloro-N-(4-imidazo[1,2-a]pyridin-2-ylphenyl)benzamide

4-chloro-N-(4-imidazo[1,2-a]pyridin-2-ylphenyl)benzamide

C20H14ClN3O (347.0825)


   

Acetic acid [2-[acetyl-(4-methylphenyl)sulfonylamino]phenyl] ester

Acetic acid [2-[acetyl-(4-methylphenyl)sulfonylamino]phenyl] ester

C17H17NO5S (347.0827)


   

(1-Methyl-3-indolyl)-diphenyl-sulfanylidenephosphorane

(1-Methyl-3-indolyl)-diphenyl-sulfanylidenephosphorane

C21H18NPS (347.0898)


   

(3s,4'r)-2-hydroxy-4'-(4-oxoquinazolin-3-yl)spiro[indole-3,2'-oxolan]-5'-one

(3s,4'r)-2-hydroxy-4'-(4-oxoquinazolin-3-yl)spiro[indole-3,2'-oxolan]-5'-one

C19H13N3O4 (347.0906)


   

(7r)-7-{[(2r)-2-amino-1-hydroxy-2-phenylethylidene]amino}-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

(7r)-7-{[(2r)-2-amino-1-hydroxy-2-phenylethylidene]amino}-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

C16H17N3O4S (347.094)


   

(6r,7r)-7-{[(2r)-2-amino-1-hydroxy-2-phenylethylidene]amino}-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

(6r,7r)-7-{[(2r)-2-amino-1-hydroxy-2-phenylethylidene]amino}-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

C16H17N3O4S (347.094)


   

(2s)-2-[(1r)-6-bromo-2-methyl-1h,3h,4h,9h-pyrido[3,4-b]indol-1-yl]-1-methylpyrrolidine

(2s)-2-[(1r)-6-bromo-2-methyl-1h,3h,4h,9h-pyrido[3,4-b]indol-1-yl]-1-methylpyrrolidine

C17H22BrN3 (347.0997)


   

7-[(4-chloro-3-methylbut-2-en-1-yl)oxy]-4,8-dimethoxyfuro[2,3-b]quinoline

7-[(4-chloro-3-methylbut-2-en-1-yl)oxy]-4,8-dimethoxyfuro[2,3-b]quinoline

C18H18ClNO4 (347.0924)


   

2-hydroxy-4'-(4-oxoquinazolin-3-yl)spiro[indole-3,2'-oxolan]-5'-one

2-hydroxy-4'-(4-oxoquinazolin-3-yl)spiro[indole-3,2'-oxolan]-5'-one

C19H13N3O4 (347.0906)


   

7-{[(2e)-4-chloro-3-methylbut-2-en-1-yl]oxy}-4,8-dimethoxyfuro[2,3-b]quinoline

7-{[(2e)-4-chloro-3-methylbut-2-en-1-yl]oxy}-4,8-dimethoxyfuro[2,3-b]quinoline

C18H18ClNO4 (347.0924)